Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company, 17678-17681 [2018-08348]

Download as PDF 17678 Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices that Nokia Solutions and Networks US LLC no longer exists as of January 1, 2018. Based on this stipulation, complainants agreed to withdraw the complaint as to Nokia Solutions and Networks B.V., Nokia Solutions and Networks Oy, and Nokia Solutions and Networks US LLC. On March 19, 2018, the ALJ issued the subject ID granting complainants’ motion. The ALJ found that good cause exists to amend the complaint and there is no evidence of any prejudice to the parties in the investigation. The ALJ found that no extraordinary circumstances prevent the partial termination of the investigation as to Nokia Solutions and Networks B.V., Nokia Solutions and Networks Oy, and Nokia Solutions and Networks US LLC. None of the parties petitioned for review of the subject ID. The Commission has determined not to review the ID. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: April 17, 2018. Lisa Barton, Secretary to the Commission. BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 22, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal DATES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on March 8, 2018, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: [FR Doc. 2018–08369 Filed 4–20–18; 8:45 am] ACTION: Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. amozie on DSK30RV082PROD with NOTICES Controlled substance Drug code 3-Fluoro-N-methylcathinone (3–FMC) ..................................................................................................................... Cathinone ................................................................................................................................................................. Methcathinone ......................................................................................................................................................... 4-Fluoro-N-methylcathinone (4–FMC) ..................................................................................................................... Pentedrone (a-methylaminovalerophenone) ........................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................ 4-Methyl-N-ethylcathinone (4–MEC) ....................................................................................................................... Naphyrone ............................................................................................................................................................... N-Ethylamphetamine ............................................................................................................................................... N,N-Dimethylamphetamine ...................................................................................................................................... Fenethylline .............................................................................................................................................................. Aminorex .................................................................................................................................................................. 4-Methylaminorex (cis isomer) ................................................................................................................................ Gamma Hydroxybutyric Acid ................................................................................................................................... Methaqualone .......................................................................................................................................................... Mecloqualone ........................................................................................................................................................... JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .......................................................................................... SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................ ADB–FUBINACA (n-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..... 5-Flouro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........ AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................. MDMB–FUBINACA (Methyl 2-(1-4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ................ 2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3- methylbutanoate ................................................................... AB–PINACA (N-(1-amino-3-methyl- ........................................................................................................................ 1-oxobutan-2-yl)-1-pentyl-1H-indazole- ................................................................................................................... 3-carboxamide) ........................................................................................................................................................ THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3- ............................................................................................................ yl](naphthalen-1-yl)methanone ................................................................................................................................ AB–CHMINACA (N-(1-amino-3-methyl-1- ............................................................................................................... oxobutan-2-yl)-1-(cyclohexylmethyl)- ....................................................................................................................... 1H-indazole-3-carboxamide ..................................................................................................................................... MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) 5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazola-3-carboxamido)-3-methylbutanoate) ...................................... 5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5fluoropentyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate) ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................... MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohenxylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanote)- ................................................................................................................................................ APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ....................................................... VerDate Sep<11>2014 17:09 Apr 20, 2018 Jkt 244001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\23APN1.SGM 23APN1 Schedule 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1503 1585 1590 2010 2565 2572 6250 7008 7010 7011 7012 7019 7020 7021 I I I I I I I I I I I I I I I I I I I I I I I I 7023 I 7024 I 7031 7032 7033 7034 7035 I I I I I 7042 7048 I I 17679 Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices amozie on DSK30RV082PROD with NOTICES Controlled substance Drug code 5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5fluoropentyl)-1H-indazole-3-carboxamide) ............................ JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .......................................................................................... SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................ JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................... JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................. UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ......................................................... JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................... JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................. AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................... JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .............................................................................................. PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ......................................................................................... 5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .................................................................... Alpha-ethyltryptamine .............................................................................................................................................. Ibogaine ................................................................................................................................................................... CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ......................................................... CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................... Lysergic acid diethylamide ...................................................................................................................................... 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ...................................................................................... Marihuana ................................................................................................................................................................ Tetrahydrocannabinols ............................................................................................................................................ Mescaline ................................................................................................................................................................. 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) .................................................................................. 3,4,5-Trimethoxyamphetamine ................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ...................................................................................................................... 4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................. 4-Methyl-2,5-dimethoxyamphetamine ...................................................................................................................... 2,5-Dimethoxyamphetamine .................................................................................................................................... JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .............................................................................................. 2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................ 3,4-Methylenedioxyamphetamine ............................................................................................................................ 5-Methoxy-3,4-methylenedioxyamphetamine .......................................................................................................... N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................... 3,4-Methylenedioxymethamphetamine .................................................................................................................... 4-Methoxyamphetamine .......................................................................................................................................... 5-Methoxy-N-N-dimethyltryptamine ......................................................................................................................... Alpha-methyltryptamine ........................................................................................................................................... Diethyltryptamine ..................................................................................................................................................... Dimethyltryptamine .................................................................................................................................................. Psilocybin ................................................................................................................................................................. Psilocyn .................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ...................................................................................................................... N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................ 1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................ 1-[1-(2-Thienyl)cyclohexyl]piperidine ....................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ...................................................................................................................... N-Benzylpiperazine .................................................................................................................................................. 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .......................................................................................... 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ............................................................................................ 2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ......................................................................................................... 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ................................................................................................ 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) .......................................................................................... 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ............................................................................................ 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ..................................................................................... 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) ........................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................... 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ............................................ 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ......................................................................................... ethanamine (25C–NBOMe) ..................................................................................................................................... 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ................................................. Methylone (3,4-Methylenedioxy-N-methylcathinone) .............................................................................................. Butylone ................................................................................................................................................................... Pentylone ................................................................................................................................................................. alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................ alpha-pyrrolidinobutiophenone (a-PBP) .................................................................................................................. AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ........................................................................................... Acetyldihydrocodeine ............................................................................................................................................... Benzylmorphine ....................................................................................................................................................... Codeine-N-oxide ...................................................................................................................................................... Desomorphine .......................................................................................................................................................... Etorphine (except HCl) ............................................................................................................................................ Codeine methylbromide ........................................................................................................................................... Dihydromorphine ...................................................................................................................................................... Heroin ...................................................................................................................................................................... VerDate Sep<11>2014 17:09 Apr 20, 2018 Jkt 244001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\23APN1.SGM 23APN1 Schedule 7049 7081 7104 7118 7122 7144 7173 7200 7201 7203 7222 7225 7249 7260 7297 7298 7315 7348 7360 7370 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 7404 7405 7411 7431 7432 7434 7435 7437 7438 7439 7455 7458 7470 7473 7493 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 7537 7538 7540 7541 7542 7545 7546 7694 9051 9052 9053 9055 9056 9070 9145 9200 I I I I I I I I I I I I I I I I 17680 Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices amozie on DSK30RV082PROD with NOTICES Controlled substance Drug code Morphine-N-oxide .................................................................................................................................................... Normorphine ............................................................................................................................................................ U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ...................................................... MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ........................................................................................... Tilidine ...................................................................................................................................................................... Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ......................................................................... Para-Fluorofentanyl ................................................................................................................................................. 3-Methylfentanyl ....................................................................................................................................................... Alpha-methylfentanyl ............................................................................................................................................... Acetyl-alpha-methylfentanyl ..................................................................................................................................... N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ............................................................................... Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ....................................................................... Butyryl Fentanyl ....................................................................................................................................................... Para-fluorobutyryl fentanyl ....................................................................................................................................... 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1phenethylpiperidin-4-yl)isobutyramide) .................................. 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ................................................................................. Para-chloroisobutyryl fentanyl ................................................................................................................................. Isobutyryl fentanyl .................................................................................................................................................... Beta-hydroxyfentanyl ............................................................................................................................................... Beta-hydroxy-3-methylfentanyl ................................................................................................................................ Alpha-methylthiofentanyl .......................................................................................................................................... 3-Methylthiofentanyl ................................................................................................................................................. Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ..................................................... Thiofentanyl ............................................................................................................................................................. Beta-hydroxythiofentanyl ......................................................................................................................................... Para-methoxybutyryl fentanyl .................................................................................................................................. Ocfentanil ................................................................................................................................................................. Valeryl fentanyl ........................................................................................................................................................ N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .................................................................. Cyclopropyl Fentanyl ............................................................................................................................................... Cyclopentyl fentanyl ................................................................................................................................................. Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ............................................................................. Amphetamine ........................................................................................................................................................... Methamphetamine ................................................................................................................................................... Lisdexamfetamine .................................................................................................................................................... Phenmetrazine ......................................................................................................................................................... Methylphenidate ....................................................................................................................................................... Amobarbital .............................................................................................................................................................. Pentobarbital ............................................................................................................................................................ Secobarbital ............................................................................................................................................................. Phencyclidine ........................................................................................................................................................... 4-Anilino-N-phenethyl-4-piperidine (ANPP) ............................................................................................................. Phenylacetone ......................................................................................................................................................... 1-Piperidinocyclohexanecarbonitrile ........................................................................................................................ Cocaine .................................................................................................................................................................... Codeine .................................................................................................................................................................... Etorphine HCl .......................................................................................................................................................... Dihydrocodeine ........................................................................................................................................................ Oxycodone ............................................................................................................................................................... Hydromorphone ....................................................................................................................................................... Ecgonine .................................................................................................................................................................. Ethylmorphine .......................................................................................................................................................... Hydrocodone ............................................................................................................................................................ Levomethorphan ...................................................................................................................................................... Levorphanol ............................................................................................................................................................. Isomethadone .......................................................................................................................................................... Meperidine ............................................................................................................................................................... Meperidine intermediate-B ....................................................................................................................................... Methadone ............................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... Morphine .................................................................................................................................................................. Thebaine .................................................................................................................................................................. Oxymorphone .......................................................................................................................................................... Thiafentanil .............................................................................................................................................................. Alfentanil .................................................................................................................................................................. Remifentanil ............................................................................................................................................................. Sufentanil ................................................................................................................................................................. Carfentanil ................................................................................................................................................................ Tapentadol ............................................................................................................................................................... Fentanyl ................................................................................................................................................................... VerDate Sep<11>2014 17:09 Apr 20, 2018 Jkt 244001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\23APN1.SGM 23APN1 9307 9313 9547 9560 9750 9811 9812 9813 9814 9815 9816 9821 9822 9823 9824 9825 9826 9827 9830 9831 9832 9833 9834 9835 9836 9837 9838 9840 9843 9845 9847 9850 1100 1105 1205 1631 1724 2125 2270 2315 7471 8333 8501 8603 9041 9050 9059 9120 9143 9150 9180 9190 9193 9210 9220 9226 9230 9233 9250 9273 9300 9333 9652 9729 9737 9739 9740 9743 9780 9801 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices The company plans to manufacture bulk controlled substances for use in product development of analytical reference standards for distribution to its customers. The company will manufacture marihuana (7360) and tetrahydrocannabinols (7370) for use by their researchers under the above-listed controlled substances as Active Pharmaceutical Ingredient (API) for clinical trials. In reference to drug code (7370) the company plans to bulk manufacture a synthetic tetrahydrocannabinol. No other activities for this drug code are authorized for this registration. proof of delivery from another delivery service such as UPS or Federal Express on or before the deadline for comments. FOR FURTHER INFORMATION CONTACT: Barbara Barron, Office of Standards, Regulations, and Variances at 202–693– 9447 (Voice), barron.barbara@dol.gov (email), or 202–693–9441 (Facsimile). [These are not toll-free numbers.] SUPPLEMENTARY INFORMATION: Section 101(c) of the Federal Mine Safety and Health Act of 1977 and Title 30 of the Code of Federal Regulations Part 44 govern the application, processing, and disposition of petitions for modification. Dated: April 13, 2018. Susan A. Gibson, Deputy Assistant Administrator. Section 101(c) of the Federal Mine Safety and Health Act of 1977 (Mine Act) allows the mine operator or representative of miners to file a petition to modify the application of any mandatory safety standard to a coal or other mine if the Secretary of Labor (Secretary) determines that: 1. An alternative method of achieving the result of such standard exists which will at all times guarantee no less than the same measure of protection afforded the miners of such mine by such standard; or 2. That the application of such standard to such mine will result in a diminution of safety to the miners in such mine. In addition, the regulations at 30 CFR 44.10 and 44.11 establish the requirements and procedures for filing petitions for modification. [FR Doc. 2018–08348 Filed 4–20–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Mine Safety and Health Administration Petitions for Modification of Application of Existing Mandatory Safety Standards Mine Safety and Health Administration, Labor. ACTION: Notice. AGENCY: This notice is a summary of petitions for modification submitted to the Mine Safety and Health Administration (MSHA) by the parties listed below. DATES: All comments on the petitions must be received by MSHA’s Office of Standards, Regulations, and Variances on or before May 23, 2018. ADDRESSES: You may submit your comments, identified by ‘‘docket number’’ on the subject line, by any of the following methods: 1. Electronic Mail: zzMSHAcomments@dol.gov. Include docket number of the petition in the subject line of the message. 2. Facsimile: 202–693–9441. 3. Regular Mail or Hand Delivery: MSHA, Office of Standards, Regulations, and Variances, 201 12th Street South, Suite 4E401, Arlington, Virginia 22202–5452, Attention: Sheila McConnell, Director, Office of Standards, Regulations, and Variances. Persons delivering documents are required to check in at the receptionist’s desk in Suite 4E401. Individuals may inspect copies of the petition and comments during normal business hours at the address listed above. MSHA will consider only comments postmarked by the U.S. Postal Service or amozie on DSK30RV082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:09 Apr 20, 2018 Jkt 244001 I. Background II. Petitions for Modification Docket Number: M–2018–006–C. Petitioner: Wolf Run Mining LLC, 21550 Barbour County Highway, Philippi, West Virginia 26416. Mine: Sentinel Mine, MSHA I.D. No. 46–04168, located in Barbour County, West Virginia. Regulation Affected: 30 CFR 75.500(d) (Permissible electric equipment). Modification Request: The petitioner requests a modification of the existing standard to permit an alternative method of compliance to allow the use of nonpermissible electronic lowvoltage or battery-powered nonpermissible electronic hand-held drill equipment in or inby the last open crosscut. The petitioner states that: (1) Nonpermissible electronic lowvoltage or battery-powered nonpermissible electronic equipment will be limited to hand-held drill equipment. (2) All other hand-held drill equipment used in or inby the last open crosscut will be permissible. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 17681 (3) Other hand-held drill equipment may be used if approved in advance by the MSHA District Manager. (4) All nonpermissible low-voltage or battery-powered nonpermissible handheld equipment to be used in or inby the last open crosscut will be examined prior to use by a certified person to ensure the equipment is being maintained in a safe operating condition. (5) The results of the examinations will be recorded and retained for one year and made available to MSHA on request. (6) A qualified person, as defined in 30 CFR 75.151, will continuously monitor for methane immediately before and during the use of nonpermissible hand-held drill equipment in or inby the last open crosscut. (7) Nonpermissible hand-held drill equipment will not be used if methane is detected in concentrations at or above 1.0 percent. When methane is detected at such level while the nonpermissible hand-held drill equipment is being used, the equipment will be deenergized immediately and withdrawn outby the last open crosscut. (8) All hand-held methane detectors will be MSHA-approved and maintained in permissible and proper operating condition as defined in 30 CFR 75.320. (9) Coal production will cease in the entry or crosscut where the nonpermissible hand-held drill equipment is in use. Accumulations of coal and combustible materials referenced in 30 CFR 75.400 will be removed before drilling begins to provide additional safety to miners. (10) Nonpermissible electronic handheld drill equipment will not be used when float coal dust is in suspension. (11) All hand-held drill equipment will be used in accordance with the manufacturer’s recommended safe use procedures. (12) Qualified personnel who use nonpermissible hand-held drill equipment will be properly trained to recognize the hazards and limitations associated with use of such equipment in areas where methane could be present. (13) The nonpermissible electronic hand-held drill equipment will not be put into service until MSHA has initially inspected the equipment and determined that it is in compliance with all of the above terms and conditions. (14) Cables supplying power to lowvoltage hand-held drill equipment will only be used when permissible handheld drill equipment is not available. Within 60 days after the Proposed Decision and Order (PDO) becomes E:\FR\FM\23APN1.SGM 23APN1

Agencies

[Federal Register Volume 83, Number 78 (Monday, April 23, 2018)]
[Notices]
[Pages 17678-17681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-08348]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Cayman 
Chemical Company

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before June 22, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on March 
8, 2018, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, 
Michigan 48108 applied to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
          Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)......            1233               I
Cathinone...............................            1235               I
Methcathinone...........................            1237               I
4-Fluoro-N-methylcathinone (4-FMC)......            1238               I
Pentedrone ([alpha]-                                1246               I
 methylaminovalerophenone)..............
Mephedrone (4-Methyl-N-methylcathinone).            1248               I
4-Methyl-N-ethylcathinone (4-MEC).......            1249               I
Naphyrone...............................            1258               I
N-Ethylamphetamine......................            1475               I
N,N-Dimethylamphetamine.................            1480               I
Fenethylline............................            1503               I
Aminorex................................            1585               I
4-Methylaminorex (cis isomer)...........            1590               I
Gamma Hydroxybutyric Acid...............            2010               I
Methaqualone............................            2565               I
Mecloqualone............................            2572               I
JWH-250 (1-Pentyl-3-(2-                             6250               I
 methoxyphenylacetyl) indole)...........
SR-18 (Also known as RCS-8) (1-                     7008               I
 Cyclohexylethyl-3-(2-
 methoxyphenylacetyl) indole)...........
ADB-FUBINACA (n-(1-amino-3,3-dimethyl-1-            7010               I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide)................
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-             7011               I
 pentyl)1H-indol-3-yl](2,2,3,3-
 tetramethylcyclopropyl)methanone.......
AB-FUBINACA (N-(1-amino-3-methyl-1-                 7012               I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide)................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).            7019               I
MDMB-FUBINACA (Methyl 2-(1-4-                       7020               I
 fluorobenzyl)-1H-indazole-3-
 carboxamido)-3,3-dimethylbutanoate)....
2-(1-(4-fluorobenzyl)-1Hindazole-3-                 7021               I
 carboxamido)-3- methylbutanoate........
AB-PINACA (N-(1-amino-3-methyl-.........            7023               I
1-oxobutan-2-yl)-1-pentyl-1H-indazole-..
3-carboxamide)..........................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-            7024               I
 3-.....................................
yl](naphthalen-1-yl)methanone...........
AB-CHMINACA (N-(1-amino-3-methyl-1-.....            7031               I
oxobutan-2-yl)-1-(cyclohexylmethyl)-....
1H-indazole-3-carboxamide...............
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-             7032               I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide)................
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-            7033               I
 indazola-3-carboxamido)-3-
 methylbutanoate).......................
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-                7034               I
 (5fluoropentyl)-1H-indazole-3-
 carboxamido)-3,3dimethylbutanoate).....
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-              7035               I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide)...........................
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-             7042               I
 (cyclohenxylmethyl)-1H-indole-3-
 carboxamido)-3,3-dimethylbutanote)-....
APINACA and AKB48 N-(1-Adamantyl)-1-                7048               I
 pentyl-1H-indazole-3-carboxamide.......

[[Page 17679]]

 
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-           7049               I
 1-(5fluoropentyl)-1H-indazole-3-
 carboxamide)...........................
JWH-081 (1-Pentyl-3-(1-(4-                          7081               I
 methoxynaphthoyl) indole)..............
SR-19 (Also known as RCS-4) (1-Pentyl-3-            7104               I
 [(4-methoxy)-benzoyl] indole...........
JWH-018 (also known as AM678) (1-Pentyl-            7118               I
 3-(1-naphthoyl)indole).................
JWH-122 (1-Pentyl-3-(4-methyl-1-                    7122               I
 naphthoyl) indole).....................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-            7144               I
 tetramethylcyclopropyl)methanone.......
JWH-073 (1-Butyl-3-(1-naphthoyl)indole).            7173               I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-           7200               I
 naphthoyl)indole)......................
AM2201 (1-(5-Fluoropentyl)-3-(1-                    7201               I
 naphthoyl) indole).....................
JWH-203 (1-Pentyl-3-(2-                             7203               I
 chlorophenylacetyl) indole)............
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-            7222               I
 3-carboxylate).........................
5F-PB-22 (Quinolin-8-yl 1-(5-                       7225               I
 fluoropentyl)-1H-indole-3-carboxylate).
Alpha-ethyltryptamine...................            7249               I
Ibogaine................................            7260               I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-                7297               I
 [(1R,3S)-3-hydroxycyclohexyl-phenol)...
CP-47,497 C8 Homologue (5-(1,1-                     7298               I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol)..............
Lysergic acid diethylamide..............            7315               I
2,5-Dimethoxy-4-(n)-                                7348               I
 propylthiophenethylamine (2C-T-7)......
Marihuana...............................            7360               I
Tetrahydrocannabinols...................            7370               I
Mescaline...............................            7381               I
2-(4-Ethylthio-2,5-dimethoxyphenyl)                 7385               I
 ethanamine (2C-T-2 )...................
3,4,5-Trimethoxyamphetamine.............            7390               I
4-Bromo-2,5-dimethoxyamphetamine........            7391               I
4-Bromo-2,5-dimethoxyphenethylamine.....            7392               I
4-Methyl-2,5-dimethoxyamphetamine.......            7395               I
2,5-Dimethoxyamphetamine................            7396               I
JWH-398 (1-Pentyl-3-(4-chloro-1-                    7398               I
 naphthoyl) indole).....................
2,5-Dimethoxy-4-ethylamphetamine........            7399               I
3,4-Methylenedioxyamphetamine...........            7400               I
5-Methoxy-3,4-methylenedioxyamphetamine.            7401               I
N-Hydroxy-3,4-methylenedioxyamphetamine.            7402               I
3,4-Methylenedioxy-N-ethylamphetamine...            7404               I
3,4-Methylenedioxymethamphetamine.......            7405               I
4-Methoxyamphetamine....................            7411               I
5-Methoxy-N-N-dimethyltryptamine........            7431               I
Alpha-methyltryptamine..................            7432               I
Diethyltryptamine.......................            7434               I
Dimethyltryptamine......................            7435               I
Psilocybin..............................            7437               I
Psilocyn................................            7438               I
5-Methoxy-N,N-diisopropyltryptamine.....            7439               I
N-Ethyl-1-phenylcyclohexylamine.........            7455               I
1-(1-Phenylcyclohexyl)pyrrolidine.......            7458               I
1-[1-(2-Thienyl)cyclohexyl]piperidine...            7470               I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine..            7473               I
N-Benzylpiperazine......................            7493               I
2-(2,5-Dimethoxy-4-methylphenyl)                    7508               I
 ethanamine (2C-D)......................
2-(2,5-Dimethoxy-4-ethylphenyl)                     7509               I
 ethanamine (2C-E ).....................
2-(2,5-Dimethoxyphenyl) ethanamine (2C-             7517               I
 H).....................................
2-(4-iodo-2,5-dimethoxyphenyl)                      7518               I
 ethanamine (2C-I)......................
2-(4-Chloro-2,5-dimethoxyphenyl)                    7519               I
 ethanamine (2C-C)......................
2-(2,5-Dimethoxy-4-nitro-phenyl)                    7521               I
 ethanamine (2C-N)......................
2-(2,5-Dimethoxy-4-(n)-propylphenyl)                7524               I
 ethanamine (2C-P)......................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl)            7532               I
 ethanamine (2C-T-4 )...................
MDPV (3,4-Methylenedioxypyrovalerone)...            7535               I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-               7536               I
 methoxybenzyl) ethanamine (25B-NBOMe)..
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-              7537               I
 methoxybenzyl).........................
ethanamine (25C-NBOMe)..................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-                7538               I
 methoxybenzyl) ethanamine (25I-NBOMe)..
Methylone (3,4-Methylenedioxy-N-                    7540               I
 methylcathinone).......................
Butylone................................            7541               I
Pentylone...............................            7542               I
alpha-pyrrolidinopentiophenone ([alpha]-            7545               I
 PVP)...................................
alpha-pyrrolidinobutiophenone ([alpha]-             7546               I
 PBP)...................................
AM-694 (1-(5-Fluoropentyl)-3-(2-                    7694               I
 iodobenzoyl) indole)...................
Acetyldihydrocodeine....................            9051               I
Benzylmorphine..........................            9052               I
Codeine-N-oxide.........................            9053               I
Desomorphine............................            9055               I
Etorphine (except HCl)..................            9056               I
Codeine methylbromide...................            9070               I
Dihydromorphine.........................            9145               I
Heroin..................................            9200               I

[[Page 17680]]

 
Morphine-N-oxide........................            9307               I
Normorphine.............................            9313               I
U-47700 (3,4-dichloro-N-[2-                         9547               I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).......................
MT-45 (1-cyclohexyl-4-(1,2-                         9560               I
 diphenylethyl)piperazine)).............
Tilidine................................            9750               I
Acryl fentanyl (N-(1-phenethylpiperidin-            9811               I
 4-yl)-N-phenylacrylamide)..............
Para-Fluorofentanyl.....................            9812               I
3-Methylfentanyl........................            9813               I
Alpha-methylfentanyl....................            9814               I
Acetyl-alpha-methylfentanyl.............            9815               I
N-(2-fluorophenyl)-N-(1-                            9816               I
 phenethylpiperidin-4-yl)propionamide...
Acetyl Fentanyl (N-(1-phenethylpiperidin-           9821               I
 4-yl)-N-phenylacetamide)...............
Butyryl Fentanyl........................            9822               I
Para-fluorobutyryl fentanyl.............            9823               I
4-Fluoroisobutyryl fentanyl (N-(4-                  9824               I
 fluorophenyl)-N-(1phenethylpiperidin-4-
 yl)isobutyramide)......................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-            9825               I
 N-phenylacetamide......................
Para-chloroisobutyryl fentanyl..........            9826               I
Isobutyryl fentanyl.....................            9827               I
Beta-hydroxyfentanyl....................            9830               I
Beta-hydroxy-3-methylfentanyl...........            9831               I
Alpha-methylthiofentanyl................            9832               I
3-Methylthiofentanyl....................            9833               I
Furanyl fentanyl (N-(1-                             9834               I
 phenethylpiperidin-4-yl)-N-phenylfuran-
 2-carboxamide).........................
Thiofentanyl............................            9835               I
Beta-hydroxythiofentanyl................            9836               I
Para-methoxybutyryl fentanyl............            9837               I
Ocfentanil..............................            9838               I
Valeryl fentanyl........................            9840               I
N-(1-phenethylpiperidin-4-yl)-N-                    9843               I
 phenyltetrahydrofuran-2-carboxamide....
Cyclopropyl Fentanyl....................            9845               I
Cyclopentyl fentanyl....................            9847               I
Fentanyl related-compounds as defined in            9850               I
 21 CFR 1308.11(h)......................
Amphetamine.............................            1100              II
Methamphetamine.........................            1105              II
Lisdexamfetamine........................            1205              II
Phenmetrazine...........................            1631              II
Methylphenidate.........................            1724              II
Amobarbital.............................            2125              II
Pentobarbital...........................            2270              II
Secobarbital............................            2315              II
Phencyclidine...........................            7471              II
4-Anilino-N-phenethyl-4-piperidine                  8333              II
 (ANPP).................................
Phenylacetone...........................            8501              II
1-Piperidinocyclohexanecarbonitrile.....            8603              II
Cocaine.................................            9041              II
Codeine.................................            9050              II
Etorphine HCl...........................            9059              II
Dihydrocodeine..........................            9120              II
Oxycodone...............................            9143              II
Hydromorphone...........................            9150              II
Ecgonine................................            9180              II
Ethylmorphine...........................            9190              II
Hydrocodone.............................            9193              II
Levomethorphan..........................            9210              II
Levorphanol.............................            9220              II
Isomethadone............................            9226              II
Meperidine..............................            9230              II
Meperidine intermediate-B...............            9233              II
Methadone...............................            9250              II
Dextropropoxyphene, bulk (non-dosage                9273              II
 forms).................................
Morphine................................            9300              II
Thebaine................................            9333              II
Oxymorphone.............................            9652              II
Thiafentanil............................            9729              II
Alfentanil..............................            9737              II
Remifentanil............................            9739              II
Sufentanil..............................            9740              II
Carfentanil.............................            9743              II
Tapentadol..............................            9780              II
Fentanyl................................            9801              II
------------------------------------------------------------------------


[[Page 17681]]

    The company plans to manufacture bulk controlled substances for use 
in product development of analytical reference standards for 
distribution to its customers.
    The company will manufacture marihuana (7360) and 
tetrahydrocannabinols (7370) for use by their researchers under the 
above-listed controlled substances as Active Pharmaceutical Ingredient 
(API) for clinical trials.
    In reference to drug code (7370) the company plans to bulk 
manufacture a synthetic tetrahydrocannabinol. No other activities for 
this drug code are authorized for this registration.

    Dated: April 13, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-08348 Filed 4-20-18; 8:45 am]
 BILLING CODE 4410-09-P